Antiva Biosciences, Inc.

Amendment
CIK: 0001563355·Biotechnology·DELAWARE·Filed: Oct 11, 2024
Total Offering

$52,999,990

Amount Sold

$38,535,985

Investors

21

First Sale

Apr 24, 2023

Offering Details

Type
Equity, Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Kristine Ball
Related Person
Gail Maderis
Related Person
Wende Hutton
Related Person
Clifford Samuel
Related Person
Beni Rovinski
Related Person
Brian Goodman
Related Person
Florencia Segal
Related Person
Elaine Chien
Related Person
Raju Gadiraju
Related Person
Sarah Walter
Related Person

Company

Antiva Biosciences, Inc.

555 Twin Dolphin Drive, Suite 620

Redwood City, CA, 94065

650-906-9229

SEC Filing

0001563355-24-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free